FDA

Scholars propose to modify the current regulatory regime for animal-based medical diagnostics.

Current testing practices in the pharmaceutical industry exploit social and racial inequities.

FDA should increase its regulatory oversight of tattoo ink safety.

CMS reconsiders a recent Medicare premium increase after restricting coverage for a controversial new drug.

FDA proposes a new rule to permit the purchase of hearing aids without a prescription.

Experts discuss regulatory options for PFAS chemical contamination control.

Scholar calls on FDA to prioritize public health by reforming medical device regulation.

The booming U.S. egg donation industry requires more regulation to safeguard donor welfare.

In regulating AI in medicine, FDA should exercise care in implementing a principles-based framework.

The structure of some essential oils companies makes it harder for federal agencies to restrain false claims.

Scholar claims that regulatory sandboxes such as emergency use authorizations boost innovation, but at a cost.

FDA warns consumers to protect themselves from a known carcinogen in hair smoothing products.